Officials push COVID-19 vaccine tests in diverse groups
It’s vital for vaccines to be tested in the hard-hit populations
TAKOMA PARK, Md. — In front of baskets of vegetables, near a sizzling burrito grill, the “promotoras” stop masked shoppers at a busy Latino farmers market: Want to test a COVID-19 vaccine?
Aided by Spanish-speaking “health promoters” and Black pastors, a stepped-up effort is underway around the U.S. to recruit minorities to ensure potential vaccines against the scourge are tested in the populations most ravaged by the virus.
Many thousands of volunteers from minority groups are needed for huge clinical trials underway or about to begin. Scientists say a diverse group of test subjects is vital to determine whether a vaccine is safe and effective for everyone, and to instill broad public confidence in the shots once they are available.
The expanded outreach by vaccine researchers and health officials is getting a late start in communities that, because of a history of scientific exploitation and racism, may be the most reluctant to roll up their sleeves.
Just getting the word out takes time.
“I didn’t know anything about the vaccine until now,” said Ingrid Guerra, who signed up last week at the farmers market in Takoma Park, Maryland.
The health promoters from CASA, a Hispanic advocacy group, explained how the research process works and how a vaccine could help end the coronavirus pandemic.
“I’m not afraid,” Guerra decided. “I want to participate for me, my family, my people.”
University of Maryland researchers agreed to set up a temporary lab at CASA’s local community center so people struggling financially wouldn’t have to travel to participate.
The hardest part, many experts say, is gaining trust.
“A white guy from the NIH is probably not going to be as effective in convincing somebody from a minority community that this is the kind of science they might want to trust, as would a doctor from their own community,” said Dr. Francis Collins, director of the National Institutes of Health.
Recruiting African Americans in particular will be “a heavy, heavy lift,” Collins said, because of the legacy of mistrust after the infamous Tuskegee experiment, when Black men in Alabama were left untreated for syphilis as part of a study that ran from the 1930s into the ’70s.
Some Black doctors, too, are wrestling with doubts. Dr. Tina Carroll-Scott, medical director of the South Miami Children’s Clinic, described a “really, really tough” time, considering the political influence the Trump administration has exerted on longtrusted health agencies, such as the Food and Drug Administration.
“Wondering whether that’s going to affect the trials, and even the vaccine that comes out, I think are all valid concerns,” said Carroll-Scott, who ultimately decided to recommend the studies. “We know that Blacks and Latinos are bearing the brunt of this virus and, yeah, we definitely need to make sure that this vaccine works for them.”
In the U.S., Black, Latino, Native Americans and Asians are more at risk of hospitalization and death from the virus. Together, they make up nearly 40% of the U.S. population and an equitable vaccine study would match those demographics, though health officials would like to see even greater numbers.